Establishment Labs Hits Five Million Motiva Devices Milestone
Event summary
- Establishment Labs has surpassed five million Motiva devices in market as of April 2026.
- The company reported over 25% revenue growth in 2025, continuing into early 2026.
- Motiva’s minimally invasive platform includes Mia Femtech and Preservé technologies.
- Preservé procedure pricing is 30% higher than standard Motiva Breast Augmentation.
The big picture
Establishment Labs’ milestone reflects strong global adoption of its breast aesthetics and reconstruction solutions. The company’s focus on science-based innovation and minimally invasive technologies positions it well in a competitive medical device market. Its ability to scale operations and maintain regulatory compliance will be critical as it expands further.
What we're watching
- Market Penetration
- How Establishment Labs will sustain its market share growth in the U.S. and globally.
- Product Innovation
- Whether the company’s minimally invasive platform can continue driving adoption rates.
- Revenue Growth
- The pace at which Establishment Labs can maintain its over 25% revenue growth trajectory.
Related topics